Exagen Inc. ( NASDAQ:XGN – Free Report ) – Analysts at William Blair lowered their Q3 2023 earnings per share (EPS) estimates for Exagen in a research report issued to clients and investors on Tuesday, August 15th. William Blair analyst A. Brackmann now forecasts that the company will post earnings per share of ($0.50) for the quarter, down from their previous forecast of ($0.45). The consensus estimate for Exagen's current full-year earnings is ($1.62) per share. William Blair also issued estimates for Exagen's Q4 2023 earnings at ($0.

https://www.dailypolitical.com/2023/08/19/q3-2023-eps-estimates-for-exagen-inc-reduced-by-analyst-nasdaqxgn.html

#dailypolitical